Profil
Daniel Dolan worked as Vice President of Financial Planning & Analysis at Radius Health, Inc. from 2020 to 2021.
Prior to that, he worked at Shire Plc as Vice President of Finance Global Product Strategy from 2016 to 2017.
Currently, he is the Chief Financial Officer at Nabriva Therapeutics Plc, a position he started in 2021 and will hold until 2023.
Dolan received his undergraduate degree and MBA from Widener University.
Ehemalige bekannte Positionen von Daniel Dolan
| Unternehmen | Position | Ende |
|---|---|---|
| NABRIVA THERAPEUTICS PLC | Finanzdirektor/CFO | 30.06.2023 |
| RADIUS HEALTH, INC. | Finanzdirektor/CFO | 15.12.2020 |
| SHIRE | Corporate Officer/Principal | 01.07.2017 |
Ausbildung von Daniel Dolan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Widener University
Widener University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nabriva Therapeutics Plc
Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
















